Investment Research & Advisory Group Inc.’s holdings in AbbVie were worth $163,000 at the end of the most recent reporting period. Marshall & Sullivan Inc. WA bought a new position in shares of AbbVie during the 2nd quarter valued at about $25,000. Abound Financial LLC acquired a new position in shares of AbbVie in the first quarter valued at approximately $30,000. AbbVie Stock PerformanceShares of ABBV stock opened at $220.75 on Monday. Also, EVP Azita Saleki-Gerhardt sold 42,370 shares of AbbVie stock in a transaction dated Tuesday, August 12th.